Literature DB >> 903697

A new method for the hydrolysis of conjugated catecholamines.

N T Buu, O Kuchel.   

Abstract

A new method of hydrolysis of conjugated CA's in plasma and urine has been developed. It is based on the lyophilization of dilute perchloric acid solutions of plasma and urine. The hydrolysis of the CA conjugates was more complete by this method than by the standard method by enzymatic hydrolysis. The identity of the products was verified by TLC. DA, undetectable in 95% of normal subjects, was found to exist almost exclusively in the conjugated form, averaging 0.74 +/- 0.17 (S.E.) ng/ml. Free and conjugated NE and E in human plasma were 0.23 +/- 0.03 and 0.32 +/- 0.27 ng/ml, respectively. The new and simple method of hydrolysis of conjugated CA's may help in the search for the physiological meaning of the conjugation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 903697

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  5 in total

1.  Urinary homovanillic acid, dopamine and norepinephrine excretion in patients with essential hypertension.

Authors:  J L Cuche; O Kuchel
Journal:  Can Med Assoc J       Date:  1978-01-21       Impact factor: 8.262

2.  [Conjugated plasma catecholamines are lower in power athletes at rest and in physical work than in untrained probands].

Authors:  M Lehmann; J Keul
Journal:  Klin Wochenschr       Date:  1985-01-02

3.  Dopamine inhibits angiotensin-stimulated aldosterone biosynthesis in bovine adrenal cells.

Authors:  T J McKenna; D P Island; W E Nicholson; G W Liddle
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

4.  Dysfunction of the adrenergic system in phosphate depleted rats.

Authors:  W Rascher; W Kreusser; H Scholz; A Schömig; R Dietz; E Ritz
Journal:  Pflugers Arch       Date:  1982-10       Impact factor: 3.657

5.  Glucuronide and sulfate catecholamine conjugates in rat and human plasma.

Authors:  J Claustre; P Serusclat; L Peyrin
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.